Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Meningioma benign
ADR ID BADD_A02706
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.09      Nervous system neoplasms benign
16.09.03      Meningiomas benign
16.09.03.001      Meningioma benign
17      Nervous system disorders
17.18      Nervous system neoplasms benign
17.18.03      Meningiomas benign
17.18.03.001      Meningioma benign
Description A relatively common neoplasm of the CENTRAL NERVOUS SYSTEM that arises from arachnoidal cells. The majority are well differentiated vascular tumors which grow slowly and have a low potential to be invasive, although malignant subtypes occur. Meningiomas have a predilection to arise from the parasagittal region, cerebral convexity, sphenoidal ridge, olfactory groove, and SPINAL CANAL. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2056-7) [MeSH]
MedDRA Code 10027192
MeSH ID D008579
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Benign meningioma | Benign neoplasm of cerebral meninges | Meningioma benign | Meningioma | Meningiomas | Xanthomatous Meningioma | Meningioma, Xanthomatous | Meningiomas, Xanthomatous | Xanthomatous Meningiomas | Angioblastic Meningioma | Angioblastic Meningiomas | Meningioma, Angioblastic | Meningiomas, Angioblastic | Angiomatous Meningioma | Angiomatous Meningiomas | Meningioma, Angiomatous | Meningiomas, Angiomatous | Clear Cell Meningioma | Clear Cell Meningiomas | Meningioma, Clear Cell | Meningiomas, Clear Cell | Fibrous Meningioma | Fibrous Meningiomas | Meningioma, Fibrous | Meningiomas, Fibrous | Hemangioblastic Meningioma | Hemangioblastic Meningiomas | Meningioma, Hemangioblastic | Meningiomas, Hemangioblastic | Hemangiopericytic Meningioma | Hemangiopericytic Meningiomas | Meningioma, Hemangiopericytic | Meningiomas, Hemangiopericytic | Intracranial Meningioma | Intracranial Meningiomas | Meningioma, Intracranial | Meningiomas, Intracranial | Intraorbital Meningioma | Intraorbital Meningiomas | Meningioma, Intraorbital | Meningiomas, Intraorbital | Intraventricular Meningioma | Intraventricular Meningiomas | Meningioma, Intraventricular | Meningiomas, Intraventricular | Malignant Meningioma | Malignant Meningiomas | Meningioma, Malignant | Meningiomas, Malignant | Meningiomas, Multiple | Meningioma, Multiple | Multiple Meningioma | Multiple Meningiomas | Meningiomatosis | Meningiomatoses | Meningotheliomatous Meningioma | Meningioma, Meningotheliomatous | Meningiomas, Meningotheliomatous | Meningotheliomatous Meningiomas | Microcystic Meningioma | Meningioma, Microcystic | Meningiomas, Microcystic | Microcystic Meningiomas | Olfactory Groove Meningioma | Groove Meningiomas, Olfactory | Meningioma, Olfactory Groove | Meningiomas, Olfactory Groove | Olfactory Groove Meningiomas | Papillary Meningioma | Meningioma, Papillary | Meningiomas, Papillary | Papillary Meningiomas | Parasagittal Meningioma | Meningioma, Parasagittal | Meningiomas, Parasagittal | Parasagittal Meningiomas | Posterior Fossa Meningioma | Meningioma, Posterior Fossa | Meningiomas, Posterior Fossa | Posterior Fossa Meningiomas | Psammomatous Meningioma | Meningioma, Psammomatous | Meningiomas, Psammomatous | Psammomatous Meningiomas | Secretory Meningioma | Meningioma, Secretory | Meningiomas, Secretory | Secretory Meningiomas | Sphenoid Wing Meningioma | Meningioma, Sphenoid Wing | Meningiomas, Sphenoid Wing | Sphenoid Wing Meningiomas | Wing Meningioma, Sphenoid | Wing Meningiomas, Sphenoid | Spinal Meningioma | Meningioma, Spinal | Meningiomas, Spinal | Spinal Meningiomas | Transitional Meningioma | Meningioma, Transitional | Meningiomas, Transitional | Transitional Meningiomas | Benign Meningioma | Benign Meningiomas | Meningioma, Benign | Meningiomas, Benign | Cerebral Convexity Meningioma | Cerebral Convexity Meningiomas | Convexity Meningioma, Cerebral | Convexity Meningiomas, Cerebral | Meningioma, Cerebral Convexity | Meningiomas, Cerebral Convexity
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00528Conjugated estrogens--
BADD_D00793Equilin sulfate--
BADD_D00831Estrogens--
BADD_D00835Estrone sulfate--
BADD_D01253Lenalidomide0.000241%
BADD_D01852Progesterone0.000125%
The 1th Page    1    Total 1 Pages